INEFFICACY OF THE HPV VACCINE SEEN BY DOCTOR OF DEEP PERÚ

May 17, 2013 By Leave a Comment
Are HPV Vaccines Necessary?

From initial infection until the appearance of cervical carcinoma (UCC) takes an average 25 to 30 years.  The research of this vaccine began in the 1990′s. It is evident that the scientific efficacy of this new vaccine will be determined somewhere around the years 2025 – 2040. HPV has not been established as THE cause [...]

[Continue reading...]
Filed Under: HPV, HPV Science, Peru Tagged With: , ,

More Gardasil Research Shenanigans?

May 17, 2013 By Leave a Comment
Informed Consent?

[SaneVax:  Dr. Chandler Marrs is a research scientist  on a mission. She believes women need adequate data on which to base their healthcare decisions - without it, there is no such thing as informed consent.   HPV vaccines are no exception. Read her analysis of a recent 'study' which has been widely quoted in the [...]

[Continue reading...]
Filed Under: Gardasil / Silgard, United States, Vaccine Science

Gardasil: Are Two Shots as Good as Three?

May 14, 2013 By Leave a Comment
2 shots as good as 3?

[SaneVax: If the news that two shots of Gardasil are capable of maintaining the same antibody level as receiving all three recommended doses, how long will it take for the CDC to alter the current recommended schedule?] Merck’s HPV Vaccine May Protect Girls With Fewer Doses By Nicole Ostrow Two doses of Merck & Co. (MRK)’s human [...]

[Continue reading...]
Filed Under: Gardasil / Silgard, United States Tagged With: ,

Marketing HPV Vaccines: Fear of Cancer Didn’t Work – Will Fear of STD’s?

May 14, 2013 By Leave a Comment
False Evidence Appearing Real?

[SaneVax: Attempts to manufacture fear of cervical cancer was not enough to convince more than 20% of eligible adolescent girls in the U.S. to submit to HPV vaccines. According to a new 'study' perhaps fear of contracting an STD will change that.  The SaneVax team issues a warning to medical consumers: Do not be fooled by new [...]

[Continue reading...]
Filed Under: HPV, United States, Vaccine Marketing Tagged With: ,

The Potential Significance of Aluminum/DNA Compounds in Gardasil on Health

May 9, 2013 By 3 Comments
Sanevax-square

By Norma Erickson Each dose of Gardasil contains 225mcg of aluminum-based adjuvant. Adjuvants are in vaccines to bring the antigen (the substance that stimulates the specific protective immune response) into contact with the immune system and influence the type of immunity produced, as well as the magnitude or duration of the immune response. In the [...]

[Continue reading...]
Filed Under: HPV, SANE Vax Press Releases, Vaccine Science, World News Tagged With: , ,

SaneVax Announces a New Gardasil Cervarix HPV Vaccine Survey

May 9, 2013 By 2 Comments
Gardasil Cervarix HPV Vaccine Survey

The SaneVax team is pleased to announce an opportunity for Gardasil and Cervarix HPV vaccine recipients and their families to help provide data regarding HPV vaccines’ risk versus benefit profile. The study is being conducted by an independent scientist, Dr. Chandler Marrs, and hosted on her website, Hormones Matter TM.  The purpose of this study [...]

[Continue reading...]
Filed Under: Cervarix, Gardasil / Silgard, SANE Vax Press Releases, World News Tagged With: , ,

Debate: Routine meningitis vaccines for infants?

May 9, 2013 By Leave a Comment
Trust me?

[SaneVax: Health authorities in the United States are currently debating whether to administer a new meningococcol vaccine to those infants at high risk for the disease, or add it to the routine immunization schedule and give it to all infants, whether they are likely to contract the disease or not. Listen to both sides of the [...]

[Continue reading...]
Filed Under: Meningitis Vaccines, United States Tagged With: ,

SaneVax response to journal article promoting proposed nine-valent HPV vaccine

May 8, 2013 By Leave a Comment
IAC-logo

[Sanevax: The following letter to the editors of Infectious Agents and Cancer was submitted as a response to "Potential impact of a nine-valent vaccine in human papillomavirus related cancers," by Sylvia de Sanjosé, et al. After peer-review and approval, the letter was published in this month's edition of Infectious Agents and Cancer.] Dear Editors In Chief: The article entitled [...]

[Continue reading...]
Filed Under: HPV, SANE Vax in the News, United States, Vaccine Marketing Tagged With: ,

Mass Vaccination: Is Society Trading Relatively Mild Childhood Diseases for Chronic Disorders?

May 8, 2013 By Leave a Comment
Risk versus Benefit

[SaneVax:  Questioning any vaccine is not a very popular activity.  Parents are caught between a rock and a hard place when it comes to trying to make informed choices about their children's health and well-being. The time has come for open, honest scientific debate about vaccines - no name-calling, recriminations or derisive comments - simply [...]

[Continue reading...]
Filed Under: Measles, United States, Vaccine Science Tagged With: ,

Autism: Don’t worry about the cause, create a vaccine for one of the symptoms?

May 7, 2013 By Leave a Comment
Vaccines: Cure or Catastrophe?

[SaneVax: Instead of seriously searching for possible causes of autism, the pharmaceutical industry has come up with the novel idea; treat one of the symptoms. Will this symptom be treated with a prescription medication for which manufacturers are liable for potential adverse effects? No! They are developing a 'vaccine'  - a medical intervention which they can [...]

[Continue reading...]
Filed Under: United States, Vaccine Science Tagged With: ,